Internal Medicine, Rheumatology · Patchogue, NY
NPI
1316213564
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
205 S Ocean Ave Fl 2
Patchogue, NY, 11772
Phone (631) 815-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$909K
39,945 services
Medicare patients, 2024
306
Average age 70
Drug cost, 2024
$5.7M
3,755 prescriptions
Company payments, 2025
$54.73
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard A Adamski II was code J0897 (injection, denosumab, 1 mg), 3,240 times for 35 patients. In total Richard A Adamski II billed 39,945 services in 46 codes, and Medicare paid $909K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,240 | 35 | $20.28 | $66K |
| J9312 Injection, rituximab, 10 mg | Office | 3,200 | 11 | $61.31 | $196K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 699 | 13 | $0.23 | $160 |
| 99214 Office E&M - Established | Office | 508 | 231 | $107.33 | $55K |
| 36415 Venipuncture Blood Collection | Office | 333 | 166 | $8.60 | $2,863 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 321 | 178 | $14.33 | $4,600 |
| 96415 Chemotherapy Administration | Office | 122 | 16 | $26.26 | $3,204 |
| 96413 Chemotherapy Administration | Office | 86 | 22 | $124.47 | $11K |
| 96374 Injection Administration | Office | 72 | 25 | $34.45 | $2,480 |
| 96372 Injection Administration | Office | 69 | 41 | $12.94 | $893 |
| 96365 Intravenous Infusion, Hydration | Office | 68 | 11 | $60.26 | $4,098 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 58 | 16 | $0.64 | $37.1 |
| 99215 Office E&M - Established | Office | 47 | 30 | $154.11 | $7,243 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 44 | 15 | $29.86 | $1,314 |
| 99204 Office E&M - New | Office | 44 | 44 | $136.04 | $5,986 |
By year: 2022 $325K for 10,603 services; 2023 $507K for 27,206 services; 2024 $909K for 39,945 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 333 | 166 | $8.60 | $2,863 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard A Adamski II prescribed most often to Medicare patients was Duloxetine Hcl, with 347 prescriptions and refills. In total Richard A Adamski II wrote 3,755 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 347 | 883 | 102 | $11K |
| Prednisone Generic | 320 | 491 | 100 | $2,296 |
| Leflunomide Generic | 243 | 546 | 68 | $16K |
| Hydroxychloroquine Sulfate Generic | 212 | 476 | 57 | $8,181 |
| Gabapentin Generic | 174 | 389 | 55 | $3,409 |
| Methotrexate Methotrexate Sodium | 159 | 357 | 41 | $4,491 |
| Etodolac Er Etodolac | 136 | 202 | 42 | $13K |
| Pregabalin Generic | 116 | 129 | 20 | $6,329 |
| Humira(Cf) Pen Adalimumab | 98 | 103 | 15 | $800K |
| Diclofenac Sodium Generic | 78 | 130 | 35 | $4,998 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 76 | 76 | 14 | $2,441 |
| Tramadol Hcl Generic | 73 | 73 | 16 | $678 |
| Cyclobenzaprine Hcl Generic | 66 | 80 | 15 | $557 |
| Meloxicam Generic | 65 | 111 | 30 | $323 |
| Celecoxib Generic | 64 | 108 | 22 | $6,067 |
Brand drugs: - claims; generic drugs: 3,238 claims; opioid claims: 248.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard A Adamski II $54.73 ($54.73 in general payments such as food, travel and fees) from 1 company. The largest payer was Fresenius Kabi USA, LLC with $54.73.
| Company | Payments | Amount |
|---|---|---|
| Fresenius Kabi USA, LLC | 2 | $54.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.